Related references
Note: Only part of the references are listed.Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis
Xu Feng et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2021)
CBP-mediated Slug acetylation stabilizes Slug and promotes EMT and migration of breast cancer cells
Xiaoyan Dai et al.
SCIENCE CHINA-LIFE SCIENCES (2021)
Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis
Hiroki Kajioka et al.
CANCER LETTERS (2021)
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
Milad Ashrafizadeh et al.
LIFE SCIENCES (2021)
STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis
Wei-Hsin Lin et al.
ONCOGENE (2021)
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
Xianglan Yi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
Sepideh Mirzaei et al.
LIFE SCIENCES (2021)
miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
Hui Zhang et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2021)
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei et al.
ANTIOXIDANTS (2021)
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
Milad Ashrafizadeh et al.
CARBOHYDRATE POLYMERS (2021)
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei et al.
PHARMACOLOGICAL RESEARCH (2021)
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh et al.
CANCER LETTERS (2021)
Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/ TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin
Ponmathi Panneerpandian et al.
TOXICOLOGY IN VITRO (2021)
FOXO3a inhibits the EMT and metastasis of breast cancer by regulating TWIST-1 mediated miR-10b/CADM2 axis
Long Jin et al.
TRANSLATIONAL ONCOLOGY (2021)
TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
Kefei Yuan et al.
CELL DEATH AND DIFFERENTIATION (2020)
Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities
Milad Ashrafizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
Jing-Yiing Wu et al.
MOLECULAR CELL (2020)
SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
Shan Tian et al.
AGING-US (2020)
SIRT1 and AROS suppress doxorubicin-induced apoptosis via inhibition of GSK3β activity in neuroblastoma cells
Jeong Woo Kim et al.
ANIMAL CELLS AND SYSTEMS (2020)
Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
Xiaoxue Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma
Avinash Gupta et al.
BRITISH JOURNAL OF CANCER (2020)
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
Eric C. Cheung et al.
CANCER CELL (2020)
Co-delivery of doxorubicin and curcumin by a pH-sensitive, injectable, and in situ hydrogel composed of chitosan, graphene, and cellulose nanowhisker
Sakineh Omidi et al.
CARBOHYDRATE POLYMERS (2020)
Doxorubicin-induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways
Ali A. Shati
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
An artificial nucleoside that simultaneously detects and combats drug resistance to doxorubicin
Jung-Suk Choi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer
Bradley J. Monk et al.
GYNECOLOGIC ONCOLOGY (2020)
Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells
De Zeng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
Francesca Rolle et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Triptolide inhibits CD133+/CD44+ colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial-mesenchymal transition via downregulating expressions of snail, slug, and twist
Eda Acikgoz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway
Yang Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis
Lei Luo et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma
Hang Lin et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2020)
Doxorubicin eluting microporous polysaccharide scaffolds: An implantable device to expunge tumour
G. U. Preethi et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling
Xiangbin Tan et al.
ONCOLOGY RESEARCH (2020)
microRNA-137 downregulates MCL1 in ovarian cancer cells and mediates cisplatin-induced apoptosis
Wei Chen et al.
PHARMACOGENOMICS (2020)
SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells
Su-Wei Xu et al.
PHARMACOLOGICAL RESEARCH (2020)
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Abeer M. Alanazi et al.
ANTIOXIDANTS (2020)
Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity
Elena Gianchecchi et al.
ANTIOXIDANTS (2020)
MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
Li Tao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5
Xiao-yun Kang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
Molecular avenues in targeted doxorubicin cancer therapy
Sayantani Roychoudhury et al.
FUTURE ONCOLOGY (2020)
Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes
Zhuo Chen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer
Xinyou Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression
Hao Wang et al.
CELL DEATH & DISEASE (2020)
Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness
Yu-Chan Chang et al.
CELL DEATH & DISEASE (2020)
Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
Shanshan Lei et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
Wei Guo et al.
SCIENTIFIC REPORTS (2020)
Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment
Xuan Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
The Emerging Roles of Exosomes as EMT Regulators in Cancer
Hyunwoo Kim et al.
CELLS (2020)
Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma
Wulin Wang et al.
ONCOLOGY REPORTS (2020)
pH-Sensitive chitosan-tripolyphosphate nanoparticles increase doxorubicin-induced growth inhibition of cervical HeLa tumor cells by apoptosis and cell cycle modulation
Daniele R. Nogueira-Librelotto et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer
Nora Feldker et al.
EMBO JOURNAL (2020)
Inhibition of Wnt/13-catenin pathway reverses multi -drug resistance and EMT in Oct4+/Nanog + NSCLC cells
Liyun Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up -regulation of PTEN in colon cancer cells
Xiaoxin Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
Jing Yang et al.
EXPERIMENTAL CELL RESEARCH (2020)
Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA
Tingsheng Yan et al.
CARBOHYDRATE POLYMERS (2020)
Ethyl pyruvate inhibits glioblastoma cells migration and invasion through modulation of NF-κB and ERK-mediated EMT
Qing Huang et al.
PEERJ (2020)
EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration
Daisy Y. Shu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Co -delivery of doxorubicin and epacadostat via heparin coated pH -sensitive to the metastasis of melanoma
Yi Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
Jong Hyun Lee et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
Li-Yan Wang et al.
WORLD JOURNAL OF CLINICAL CASES (2020)
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Milad Ashrafizadeh et al.
BIOMOLECULES (2020)
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy
Milad Ashrafizadeh et al.
BIOMOLECULES (2020)
Preparation of doxorubicin-loaded collagen-PAPBA nanoparticles and their anticancer efficacy in ovarian cancer
Haiyan Jiang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Maria Victoria Recouvreux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
New molecular and biochemical insights of doxorubicin-induced hepatotoxicity
Pureti Lakshmi Prasanna et al.
LIFE SCIENCES (2020)
LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p
Baiqi Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma
Yasaman Fahim et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
Florian Gauthier et al.
MOLECULES (2020)
Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized Poly (ε-caprolactone) based micelle in MDA-MB-231 cell
Amin Sabzi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells - Role of Snail, Slug and Twist and Small Molecule Inhibitors
Ezgi Kasikci et al.
ONCOTARGETS AND THERAPY (2020)
Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma
Ping Yang et al.
ONCOTARGETS AND THERAPY (2020)
TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer
Bit Na Kim et al.
Scientific Reports (2020)
Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
Gyorgy Babos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
Milad Ashrafizadeh et al.
LIFE SCIENCES (2020)
Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro
Jianfei Xu et al.
LIFE SCIENCES (2020)
New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
Cristina Alexandra Ciocan-Cartita et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Curcumin induces chemosensitization to doxorubicin in Duke's type B coloadenocarcinoma cell line
Jeyan Jayarajan et al.
MOLECULAR BIOLOGY REPORTS (2020)
Primary and Secondary Markers of Doxorubicin-Induced Female Infertility and the Alleviative Properties of Quercetin and Vitamin E in a Rat Model
Mohammad Samare-Najaf et al.
REPRODUCTIVE TOXICOLOGY (2020)
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3
Mengxian Tu et al.
CELL DEATH & DISEASE (2020)
Flavokawain B and Doxorubicin Work Synergistically to Impede the Propagation of Gastric Cancer Cells via ROS-Mediated Apoptosis and Autophagy Pathways
You-Cheng Hseu et al.
CANCERS (2020)
Angiotensin Inhibition, TGF-beta and EMT in Cancer
Fabian Bernhard Pallasch et al.
CANCERS (2020)
Doxorubicin and Trifolium pratense L. (Red clover) extract synergistically inhibits brain and lung metastases in 4T1 tumor-bearing BALB/c mice
Mohsen Akbaribazm et al.
FOOD SCIENCE & NUTRITION (2020)
Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade
Sun Tae Hwang et al.
BIOMOLECULES (2020)
Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner
Wei Yu et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2020)
Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway
Xiaomin Li et al.
DIAGNOSTIC PATHOLOGY (2020)
Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
Yuzhu Hu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Interactions Between lncRNA TUG1 and miR-9-5p Modulate the Resistance of Breast Cancer Cells to Doxorubicin by Regulating eIF5A2
Shuqian Wang et al.
ONCOTARGETS AND THERAPY (2020)
RNF20 Is Critical for Snail-Mediated E-Cadherin Repression in Human Breast Cancer
Danping Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Exosomal Transfer of Macrophage-Derived miR-223 Confers Doxorubicin Resistance in Gastric Cancer
Huijie Gao et al.
ONCOTARGETS AND THERAPY (2020)
Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
Milad Ashrafizadeh et al.
PHARMACEUTICS (2020)
Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy
Kang Xiong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
Milad Ashrafizadeh et al.
BIOENGINEERING-BASEL (2020)
Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN
Zhiqiang Li et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
Stanislav Drapela et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Pien Tze Huang Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells
Xi Chen et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2019)
Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
Jiabei He et al.
CELL DEATH & DISEASE (2019)
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer
Xiaoxia Jin et al.
CANCER MEDICINE (2019)
Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
Claudia Christowitz et al.
BMC CANCER (2019)
Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin
Javier Menendez-Menendez et al.
CANCERS (2019)
Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway
Yangwei Fan et al.
CANCER BIOLOGY & THERAPY (2019)
ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells
Lin Long et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells
Jalal Choupani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
Jong Hyun Lee et al.
PHARMACOLOGICAL RESEARCH (2019)
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Feiya Du et al.
CELL DEATH & DISEASE (2019)
Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
Zhili Ma et al.
THERANOSTICS (2019)
Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition
Jorge Gomez Tejeda Zanudo et al.
PHYSICAL BIOLOGY (2019)
Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles
Manisha Kumari et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial-mesenchymal transition through the Notch1 signaling pathway
Wenxue Liu et al.
CANCER MEDICINE (2018)
Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells
Liang Fang et al.
JOURNAL OF CANCER (2018)
MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7
Jieqiong Ding et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells
Logeswari Ponnusamy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
Jiahui Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
Shihua Chu et al.
ONCOLOGY REPORTS (2017)
Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma
Meiling Yu et al.
ONCOLOGY REPORTS (2017)
The inhibitory effects of deep-sea water on doxorubicin-induced epithelial-mesenchymal transition
So-Young Chun et al.
ONCOLOGY REPORTS (2017)
Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
Jian Yang et al.
ONCOLOGY LETTERS (2017)
DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition
Xing Kang et al.
ONCOTARGET (2017)
Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells
Sarala Manandhar et al.
ONCOTARGET (2017)
Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma
Jie-Xue Pan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
Yangyan Jiang et al.
BMC CANCER (2016)
Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line
Raimonda Kubiliute et al.
MEDICINA-LITHUANIA (2016)
Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Xiaoyun Dai et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation
Hong-Jen Lee et al.
MOLECULAR CELL (2016)
Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line
Raimonda Kubiliute et al.
MEDICINA-LITHUANIA (2016)
PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma
Szu-Ting Lin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Xin Ye et al.
TRENDS IN CELL BIOLOGY (2015)
Connexins: junctional and non-junctional modulators of proliferation
Trond Aasen
CELL AND TISSUE RESEARCH (2015)
An Epigenetic Mechanism Underlying Doxorubicin Induced EMT in the Human BGC-823 Gastric Cancer Cell
Rong-Fei Han et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
Annie Ng et al.
NATURE CELL BIOLOGY (2014)
Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
Asfar S. Azmi
CURRENT CANCER DRUG TARGETS (2013)
Curcumin Suppresses Doxorubicin-Induced Epithelial-Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
Wei-Chih Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
Activation of β-catenin signaling is critical for doxorubicin-induced epithelial-mesenchymal transition in BGC-823 gastric cancer cell line
Rongfei Han et al.
TUMOR BIOLOGY (2013)
Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
Eleftherios Sachlos et al.
CELL (2012)
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
Wim de Lau et al.
NATURE (2011)
Gap junctions and connexins as therapeutic targets in cancer
Mustapha Kandouz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Gap Junctions and Cancer: New Functions for an Old Story
Laurent Cronier et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Gap junction- and hemichannel-independent actions of connexins
JX Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Gap junctions as targets for cancer chemoprevention and chemotherapy
JE Trosko et al.
CURRENT DRUG TARGETS (2002)
Share Paper
